News & Updates

Show Multimedia Only

Large study measures antimicrobial resistance burden in healthcare-associated infections in Asia

Antimicrobial resistance (AMR) in ventilator-associated pneumonia and bloodstream infections in Asia is common and associated with high mortality rates and reduced quality of life, as shown in the ACORN-HAI study.

Large study measures antimicrobial resistance burden in healthcare-associated infections in Asia

a day ago

Azithromycin benefit in unscheduled cesarean delivery confirmed in real world

25 Sep 2026 by

Adjunctive azithromycin use during unscheduled cesarean deliveries has increased following the landmark C/SOAP trial in 2016, resulting in a decrease in postpartum infection rates in a real-world US cohort.

Azithromycin benefit in unscheduled cesarean delivery confirmed in real world

25 Sep 2026

Atypical otitis media prevalent in older children, tied to distinct disease phenotypes

25 Sep 2026

Atypical otopathogens of otitis media (OM) are more commonly detected in older children and correlate with distinct disease phenotypes but similar outcomes to typical pathogens, according to a study.

Atypical otitis media prevalent in older children, tied to distinct disease phenotypes

25 Sep 2026

Two-drug noninferior to three-drug ART as initial HIV treatment

24 Sep 2026 by

In individuals with untreated HIV-1 infection, the two-drug dolutegravir/lamivudine (DTG/3TC) antiretroviral therapy (ART) regimen has similar efficacy as the three-drug bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen, according to the phase IIIb VOGUE study.

Two-drug noninferior to three-drug ART as initial HIV treatment

24 Sep 2026

KD seasonality shifts from winter to summer after COVID-19 pandemic

24 Sep 2026

A 10-year study in Japan has found that the seasonality of Kawasaki Disease (KD) has not returned to the usual winter-dominant pattern even after lifting the COVID-19 infection mitigation measures.

KD seasonality shifts from winter to summer after COVID-19 pandemic

24 Sep 2026

Pharmacist-led provider education improves antimicrobial discharge prescriptions

23 Sep 2026

A pharmacist-led provider education results in better prescribing patterns for antimicrobial discharge prescriptions, according to a study.

Pharmacist-led provider education improves antimicrobial discharge prescriptions

23 Sep 2026

Supporting long-term HIV treatment success: Real-world durability of B/F/TAF

18 Sep 2026 by

Advances in antiretroviral therapy (ART) have transformed HIV management, with life expectancy among people living with HIV (PLHIV) now comparable to that of the general population. This makes choosing a durable regimen that can sustain treatment success over the long term increasingly important. Recent real-world evidence highlights the durability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF), an integrase strand transfer inhibitor (INSTI)–based three-drug regimen, in both treatment-naïve and treatment-experienced settings.

Supporting long-term HIV treatment success: Real-world durability of B/F/TAF

18 Sep 2026

Long-term bulevirtide treatment safe, effective for chronic hepatitis D

17 Sep 2026 by

Treatment with bulevirtide monotherapy for up to 144 weeks is safe, well tolerated, and effective in patients with chronic hepatitis D (CHD), a study has shown.